Interleukin-18: A novel cytokine in inflammatory rheumatic disease
Open Access
- 9 July 2001
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (7) , 1481-1483
- https://doi.org/10.1002/1529-0131(200107)44:7<1481::aid-art268>3.0.co;2-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's diseaseArthritis & Rheumatism, 2001
- Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's diseaseArthritis & Rheumatism, 2001
- Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18The Journal of Immunology, 2001
- An IFN-γ-Independent Proinflammatory Role of IL-18 in Murine Streptococcal Cell Wall ArthritisThe Journal of Immunology, 2000
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000
- A proinflammatory role for IL-18 in rheumatoid arthritisJournal of Clinical Investigation, 1999
- Interleukin-18Methods, 1999
- TNFα and response of treatment-resistant adult-onset Still's disease to thalidomideThe Lancet, 1998
- Defective NK Cell Activity and Th1 Response in IL-18–Deficient MiceImmunity, 1998
- Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.Journal of Clinical Investigation, 1998